Weight loss peptides beyond GLP-1: what the evidence shows for each
Mostly no, or at least not yet proven. Semaglutide and tirzepatide are the only peptides in this conversation that are FDA-approved for chronic weight management and backed by large randomized trials. Tesamorelin is FDA-approved only to reduce excess abdominal fat in adults with HIV-associated lipodystrophy, while AOD-9604, MOTS-c, sermorelin and lipotropic shots lack controlled human evidence of meaningful weight loss. Treat them as optional, experimental add-ons, not the engine of your program.
That distinction matters because many "metabolic reset" programs bundle these add-ons with a GLP-1 and market the whole package as one result. Here is how each one grades on the evidence that actually exists.
| Peptide or shot | FDA status | Best human evidence | Evidence grade |
|---|---|---|---|
| Semaglutide (Wegovy) | Approved for chronic weight management | Large randomized controlled trials | Strong |
| Tirzepatide (Zepbound) | Approved for chronic weight management | Large randomized controlled trials | Strong |
| Tesamorelin | Approved only for excess abdominal fat in adults with HIV lipodystrophy | Randomized trials in that population | Narrow: not a general weight-loss drug |
| AOD-9604 | Not approved for any use | Limited; no established weight-loss benefit | Weak |
| MOTS-c | Not approved for any use | Mostly animal and early-stage research | Preliminary |
| Sermorelin, ipamorelin, CJC-1295 | Not approved for weight loss | Little fat-loss data | Weak |
| Lipotropic and B-vitamin shots | Not approved for weight loss | Little controlled evidence | Weak |
Semaglutide and tirzepatide: the proven core
It is easy to forget that semaglutide and tirzepatide are peptides too. Semaglutide mimics the gut hormone GLP-1. Tirzepatide acts on both the GLP-1 and GIP receptors. As Wegovy and Zepbound, both are FDA-approved for chronic weight management in adults with obesity, or with overweight plus at least one weight-related health condition.
That approval rests on large, placebo-controlled randomized trials in which people taking the medication, alongside diet and activity changes, lost substantially more weight than people on placebo. No other peptide in this article comes close to that level of evidence.
They are not risk-free. Nausea and other digestive side effects are common, especially as the dose climbs, and both labels carry warnings your prescriber should review with you. That is why dosing starts low and escalates gradually, then moves to a maintenance phase.
At BioCure, semaglutide and tirzepatide are weekly injections with escalating doses, followed by maintenance, and both require a consultation and a blood panel first. You can see how the program is structured on our medical weight loss page.
AOD-9604: a growth hormone fragment without proven results
AOD-9604 is a modified fragment of human growth hormone, developed to isolate the hormone's effects on fat metabolism without its effects on growth. It was studied as an obesity treatment but never reached FDA approval, and it is not approved for any use today. Published controlled human data have not established that it produces meaningful weight loss.
You may see claims online that AOD-9604 builds muscle or improves bone density. Treat those with caution: they are not backed by the kind of controlled human trials that support GLP-1 medications.
BioCure offers AOD-9604 alongside semaglutide and tirzepatide. If you and your physician decide to try it, go in with clear expectations: it is an experiment, tracked against your labs, weight and body composition, not a substitute for a proven medication. Whether a pharmacy can compound it at any given time also depends on FDA's bulk-substance categories, covered below.
MOTS-c: interesting science, early evidence
MOTS-c is a small peptide encoded in mitochondrial DNA, the genetic material inside your cells' energy factories. Researchers are interested in it because of its apparent role in how cells handle glucose and energy. Most of what is known comes from cell and animal studies; human data are early and small.
That makes MOTS-c a reasonable topic for longevity research and a poor candidate for promises about fat loss. If you compete in tested sport, note that MOTS-c appears on the WADA 2026 Prohibited List.
BioCure includes MOTS-c among its peptide therapy protocols, prescribed after an evaluation and labs. For a deeper look at the science, read our post on MOTS-c and mitochondrial aging research.
Tesamorelin, sermorelin and other growth hormone secretagogues
These peptides prompt your pituitary gland to release more of your own growth hormone. They work differently from GLP-1 drugs, which act mainly on appetite and blood sugar regulation.
Tesamorelin is the only one with an FDA approval connected to fat: it is approved to reduce excess abdominal fat in adults with HIV-associated lipodystrophy. In that population, randomized trials showed reductions in deep abdominal (visceral) fat. It is not approved as a general weight-loss drug, and using it outside that indication is off-label. We compare the two approaches in tesamorelin vs GLP-1.
Sermorelin, ipamorelin and CJC-1295 have little controlled data on weight or fat loss in healthy adults. Some people use them for sleep, recovery or body composition goals, but weight loss is not where their evidence lies.
Two practical cautions. First, growth hormone can raise blood sugar, which deserves monitoring if you are also working on metabolic health. Second, the WADA 2026 Prohibited List bans growth hormone releasing hormone analogues, including sermorelin and tesamorelin, so athletes should avoid them. BioCure offers sermorelin within its peptide therapy program after labs.
Lipotropic and amino-acid B-vitamin shots
Lipotropic injections usually combine amino acids or nutrients such as methionine, inositol and choline with B vitamins. BioCure's version is Lipomino, an amino acid and B-vitamin injection. There is little controlled evidence that these shots cause weight loss on their own.
Where they can make sense is narrower: if your blood work shows you are low in vitamin B12, correcting that deficiency can help with energy and general health. Think of these shots as support for the plan, not a fat burner.
Where FDA stands on compounded peptides and GLP-1 ingredients
Two FDA actions shape what clinics can offer.
The Category 2 list. FDA keeps a list of bulk drug substances nominated for compounding that may present significant safety risks. Substances in Category 2 fall outside the interim policy that lets pharmacies compound certain nominated ingredients while FDA reviews them. Several peptides sold by wellness clinics have appeared on this list, and FDA's approach to peptides has been the subject of public debate, which we cover in the FDA shake-up and the peptide comeback. Because the list can change, ask your clinic to confirm a peptide's current status before you start.
The GLP-1 green list. FDA launched a green list to help keep illegal imported GLP-1 drug ingredients out of the U.S. supply. That is a direct response to unsafe semaglutide and tirzepatide ingredients entering the market.
Before you start any compounded product, ask:
- Which licensed pharmacy prepares it?
- Where does the active ingredient come from?
- Is the peptide currently allowed for compounding?
- Who reviews your labs and adjusts your dose?
What a real "metabolic reset" program should include
"Metabolic reset" is a marketing phrase, not a medical term. National telehealth programs such as Ro, Found and Calibrate build around prescription medication with ongoing support, while many local clinics add peptides on top. Check each program's own site for what is included and how pricing works. Whoever you choose, a credible program should have these parts:
| Component | Why it matters |
|---|---|
| Baseline and follow-up labs | Confirms you are a candidate and tracks safety |
| A proven medication when appropriate | GLP-1 drugs carry the strongest evidence |
| Physician supervision and dose adjustments | Side effects and plateaus need clinical judgment |
| Nutrition, protein and strength training | Protects muscle while you lose fat |
| A maintenance plan | Weight management continues after you reach goal |
| Honest labels on add-ons | You know what is proven and what is experimental |
BioCure's weight-loss program is physician-led and built on that structure. You start with a roughly 5-minute online intake, then a $199 video consultation with a physician that can be credited back with a membership. Diagnostics run through an at-home kit with an in-home phlebotomist or in a lab, using a comprehensive panel of 90+ biomarkers, with results in 7 to 14 days. Your physician reviews the results with you one on one, builds your protocol, and medications ship to your door. AOD-9604, Lipomino, MOTS-c and sermorelin are available where they fit your goals, labeled for what they are. BioCure does not bill insurance directly, but many patients use HSA or FSA funds, and we provide documentation for reimbursement. We treat patients in 47 states, and availability in your state is confirmed at intake.
Frequently asked questions
Does AOD-9604 actually work for weight loss?
AOD-9604 is not FDA-approved for any use, and published controlled human trials have not established that it produces meaningful weight loss. Some people try it as an add-on, but it should not replace a proven treatment. If you use it, track results against your labs and body composition with your physician.
Is MOTS-c good for fat loss?
MOTS-c is a mitochondrial peptide studied for its role in glucose and energy metabolism, but most of the evidence comes from cell and animal studies. Human data are early, so fat-loss benefits are unproven. It also appears on the WADA 2026 Prohibited List, which matters for tested athletes.
Can I take tesamorelin for weight loss if I don't have HIV?
Tesamorelin is FDA-approved only to reduce excess abdominal fat in adults with HIV-associated lipodystrophy, so any other use is off-label. It is not approved as a general weight-loss drug. It can also affect blood sugar, which needs monitoring.
Are lipotropic B12 shots worth it for weight loss?
There is little controlled evidence that lipotropic or amino-acid B-vitamin shots cause weight loss. They are most useful when blood work shows a deficiency, such as low B12. Think of them as support, not a fat burner.
Can you combine peptides with semaglutide or tirzepatide?
Some clinics, including BioCure, offer peptides alongside GLP-1 medications under physician supervision. The GLP-1 drug carries the proven effect, and add-ons are experimental. Your physician should review your labs and medications before combining anything.
Are compounded weight loss peptides legal?
It depends on the peptide and FDA's current compounding categories. FDA keeps a Category 2 list of bulk substances that may present significant safety risks, and it launched a green list to block illegal imported GLP-1 ingredients. Ask any clinic which licensed pharmacy prepares your medication and whether the peptide is currently allowed.
The honest takeaway: build your plan on the medication with the strongest evidence, support it with labs, nutrition and strength training, and treat every add-on as an experiment you measure. Longevity is not accidental, it is intentional, and so is lasting weight loss.
Let BioCure Health lead you in the right direction. Call or text us to schedule an introductory call at 754-206-0838. Your future self will thank you.